Hair Loss Medication Market: Ageing Population is to be Doubled by 2026 to Reach 98 Million

The market report titled ‘Global Hair Loss Medication Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

The prevalence rate of hair-loss is high among the working age population. As per the International Society of Hair Restoration Surgery, 84.6% of individuals who got hair-loss treatment in 2018 was due to genetic hair loss.

Hair Loss Medication Market Dynamics
The significant drivers driving the market are changing lifestyle patterns, adoption of a hectic schedule that increases stress levels, which in turn results in frequent hair loss at earlier stages among the young population, growing disposable income and increased emphasis on appearances.
According to National Alopecia Areata Foundation (NAAF), the prevalence of hair loss has increased in the age group of 10 to 25 years in the last decade, and around 60% of this age group suffers from hair loss. As per the American Hair Loss Association, more than 66% of men below the age of 35 experienced hair loss problems in the year 2018. Besides, about 85% of the men below the age of 55 are expected to face thinning of hair. More than 21 million women are suffering from severe hair loss problems with about 40% of them getting active treatments.

Request for a free sample of the report -https://www.datamintelligence.com/research-report/hair-loss-medication-market

Hair Loss Medication Market Restraints
The presence of an alternative treatment option for hair-loss such as hair transplant surgery, laser, and light-based therapies and the high cost of medication is going to restrain the market in the forecast period.

Hair Loss Medication Market Size Analysis
By Drug Type, the global hair loss medication market is segmented into Vasodilators (Minoxidil), 5-Alpha Reductase Inhibitors (Finasteride), Corticosteroids, Immunosuppressants (Cyclosporine) and others.
By gender, the market is segmented into male, female and children.
By route of administration, the market is segmented into oral, topical and injectable.
By distribution channel, the market is segmented into hospital, retail pharmacies, online pharmacies, and others.

Hair Loss Medication Market Regional Share
Geographically, the global hair loss medication market is divided into North America, Europe, South America, Asia-Pacific and the rest of the world.
North America is having a huge market for hair loss medication and is going to dominate the market throughout the forecast followed by Europe.
According to the American Hair Loss Association, more than 80 million men and women are suffering from hair loss problems in the US alone. There are many positive initiatives taken by organizations such as NAAF and the American Hair Loss Association.
According to the Eurostat, the population in the European Union between 15-64 years is expected to decline by 2060, while the population above 60 years is expected to grow from 18% to 30%.
Similarly, in America, the aging population is forecasted to be doubled by 2060 to reach 98 million. Increased hair loss problems due to aging have strongly affected the market growth.

Hair Loss Medication Market Competitive Landscape
Cipla, Merck & Co., Johnson & Johnson, Lifes2good, Dr. Reddy’s Laboratories, Sun Pharma, Kirkland Signature, Histogen Inc., GlaxoSmithKline plc. And L`Oreal S.A. is some of the major players in the market.
In May 2018, Histogen, Inc., received approval of its investigational new drug application from the U.S. Food and Drug Administration (FDA) to study its first product Hair Stimulating Complex (HSC660) in female diffuse hair loss. HSC660 is an investigational injectable treatment for alopecia and is expected to get FDA approval shortly.

Read more information about the research report - https://www.datamintelligence.com/research-report/hair-loss-medication-market

Table of contents -
1. Hair Loss Medication Market – Scope and Methodology
2. Hair Loss Medication Market Trends
3. Hair Loss Medication Market Outlook
4. Hair Loss Medication Market – Segmentation Analysis
4.1. By Drug Type
4.2. By Gender
4.3. By Route of Administration
4.4. By Distribution Channel
5. Hair Loss Medication Market – Regional, Country-level Analysis
5.1. Geographic Overview
5.2. North America
5.3. Europe
5.4. South America
5.5. Asia Pacific
5.6. Rest of the World
6. Hair Loss Medication Market – Competitive Analysis
7. Hair Loss Medication Market – Company Profiles
8. Hair Loss Medication Market – Key companies to watch
9. Hair Loss Medication Market – Emerging companies
10. Hair Loss Medication Market – Appendix

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

Copyright © 2019 DataM Intelligence. All Rights Reserved

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

This release was published on openPR.